u/line_demir

everything else in the vial drawer, identity

Adding to this: TB-500 is doing more work than the comment implies.

Crossposting this to c/coa because the people who need it are not reading this community.

non-scale victories count, post them

customs clearance often adds 4 days, factor that in

off-label use data is different from approved-indication data

Sceptical. If this were true we would see it reflected in the data and we do not.

Slight fix: the number was 95.1, not 94.2.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

Yeah, identity is the first question.

the 18 week readout is different from the 27 week readout

Strongly agree. Phase 2 is investigational, not conclusive.

Phase 2 or phase 3?

the discontinuation arms are the interesting part, not the endpoint endpoints

Denmark to Denmark: QYB with 4 days is the average, variance is 15

This is correct.

Disagree on that part. 99.2% and 98.9% on the same vial is normal.

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

absolute risk reduction, not relative risk reduction, that is how you decide

thymosin fragments, GH secretagogues, TB-500, long tail

The thing nobody prepared me for was the quiet. Not the appetite, the quiet. The constant negotiation in my head about food just stopped.

Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.

text removes the comparison trap